TrialNature medicine2026
Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial.
Huiyuan Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
TrialNature medicine2026
Huiyuan Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.